Subsidised CGM has not improved outcomes in Australian children with T1D

Australia’s program of providing subsidised CGM devices for young people with type 1 diabetes has not resulted in improved glycaemic control or reduced rates of severe hypoglycaemia, experience at a Melbourne tertiary centre has shown. Two year outcomes for a cohort of 341 patients under 21 years of age who started CGM at Melbourne’s Royal ...

Already a member?

Login to keep reading.

© 2021 the limbic